America calls and raises the AI bet with the B-21 Raider stealth bomber.
U.S Air Force.
This incident, whose timing peculiarly lined up with Chinese Premier Xi Jinping’s visit to the United States, caused China to suddenly change tact and want to talk about nukes and AI.
AI with image recognition opens up new possibilities for designers and developers to quickly turn an idea into a prototype. There are several approaches based on OpenAI technology.
The introduction of multimodal capabilities in GPT-4 has laid an important foundation for future software development. Thanks to GPT-4V, the AI model accepts both text and images as input. This allows it to generate working code from screenshots or rudimentary drawings.
Recently, several products have been developed around this idea. The collaborative whiteboard tool tldraw has set up a playground on the website makereal.tldraw.com, where mockups of website elements can be created in the browser. GPT-4V converts these into code using the OpenAI API. A separate API key is required.
The same question has also been lurking behind the OpenAI leadership struggle — in which CEO Sam Altman won out over the nonprofit board members who fired him a week earlier.
Sumit Rana, head of research and development, discusses how the EHR giant’s system uses AI to generate progress notes, create draft responses to patient questions and assist with medical coding. And how AI sometimes can be more empathetic than a person.
Summary: Dopamine, a neurotransmitter, plays a vital role in encoding both reward and punishment prediction errors in the human brain.
This study suggests that dopamine is essential for learning from both positive and negative experiences, enabling the brain to adapt behavior based on outcomes. Using electrochemical techniques and machine learning, scientists measured dopamine levels in real-time during a computer game involving rewards and penalties.
The findings shed light on the intricate role of dopamine in human behavior and could have implications for understanding psychiatric and neurological disorders.
Researchers at Tufts University and Harvard University’s Wyss Institute have created tiny biological robots that they call Anthrobots from human tracheal cells that can move across a surface and have been found to encourage the growth of neurons across a region of damage in a lab dish.
The multicellular robots, ranging in size from the width of a human hair to the point of a sharpened pencil, were made to self-assemble and shown to have a remarkable healing effect on other cells. The discovery is a starting point for the researchers’ vision to use patient-derived biobots as new therapeutic tools for regeneration, healing, and treatment of disease.
The work follows from earlier research in the laboratories of Michael Levin, Vannevar Bush Professor of Biology at Tufts University School of Arts & Sciences, and Josh Bongard at the University of Vermont in which they created multicellular biological robots from frog embryo cells called Xenobots, capable of navigating passageways, collecting material, recording information, healing themselves from injury, and even replicating for a few cycles on their own.
Regenerative medicine might just have had a new tool added to its arsenal: Scientists have created tiny biological robots out of living human cells. Though they may be small, the self-assembling bots are mighty, with a study demonstrating their potential for healing and treating disease.
The team had already proven their biological robotics chops back in 2020 with the creation of Xenobots, made from frog embryonic cells. They even managed to design Xenobots so that they could reproduce in a way that no living animal or plant does, something that had never been seen before.
The researchers weren’t sure whether the incredible capabilities of the Xenobots were in some way down to their amphibious origins, so they wanted to find out if biobots could also be created from the cells of other organisms. And why not begin with humans?